In founding Modifi Biosciences, we sought to radically change the oncology treatment paradigm for cancer patients with glioblastoma and other tumors,” said Ranjit S. Bindra, MD, PhD, Modifi ...

MSD has acquired US cancer therapeutics developer Modifi Biosciences, a Yale University spinout, enhancing its portfolio with ...

Connecticut, USA-based Modifi Biosciences today announced that the company has been acquired by pharma giant Merck & Co (NYSE ...

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair ...

The acquisition strengthens Merck's oncology portfolio as the company looks to off the expiration of the patent for ...

Current health news covers Roche's opposition to Catalent's takeover, cost analysis of weight-loss drugs like Wegovy, U.S.

Advisers to the Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults ...

Modifi Biosciences announced that it has been acquired by global pharmaceutical giant Merck, with a $30 million down payment.

In a report released today, Charlie CY Yang from Bank of America Securities maintained a Buy rating on Merck & Company (MRK – ...

Merck (MRK) announced that the European Commission (EC) has approved two new indications for Keytruda, Merck’s anti-PD-1 therapy, in ...

Kamala Harris is not offering sweeping change, even as voters express dissatisfaction about the direction of the country. She’s an institutionalist who wants to preserve democratic ideals, and ...